Biora Therapeutics Analyst Ratings
Biora Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | 1637.97% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 05/16/2023 | 1637.97% | HC Wainwright & Co. | → $65 | Reiterates | Buy → Buy |
| 01/10/2023 | 1637.97% | HC Wainwright & Co. | $6 → $65 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 07/27/2023 | 1637.97% | HC Wainwright & Co. | → 65 美元 | 重申 | 購買 → 購買 |
| 05/16/2023 | 1637.97% | HC Wainwright & Co. | → 65 美元 | 重申 | 購買 → 購買 |
| 01/10/2023 | 1637.97% | HC Wainwright & Co. | 6 美元 → 65 美元 | 維護 | 購買 |
What is the target price for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的目標價格是多少？
The latest price target for Biora Therapeutics (NASDAQ: BIOR) was reported by HC Wainwright & Co. on July 27, 2023. The analyst firm set a price target for $65.00 expecting BIOR to rise to within 12 months (a possible 1637.97% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年7月27日公佈了Biora Therapeutics（納斯達克股票代碼：BIOR）的最新目標股價。這家分析公司將目標股價定爲65.00美元，預計BIOR將在12個月內升至12個月內（可能上漲1637.97％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Biora Therapeutics (BIOR)?
分析師對Biora Therapeutics（BIOR）的最新評級是多少？
The latest analyst rating for Biora Therapeutics (NASDAQ: BIOR) was provided by HC Wainwright & Co., and Biora Therapeutics reiterated their buy rating.
Biora Therapeutics（納斯達克股票代碼：BIOR）的最新分析師評級由HC Wainwright & Co. 提供，Biora Therapeutics重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Biora Therapeutics (BIOR)?
Biora Therapeutics（BIOR）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biora Therapeutics was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Biora Therapeutics的高管和客戶交談，以及聽取財報電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Biora Therapeutics的最後一次評級是在2023年7月27日提交的，因此你應該預計下一個評級將在2024年7月27日左右公佈。
Is the Analyst Rating Biora Therapeutics (BIOR) correct?
分析師對 Biora Therapeutics (BIOR) 的評級正確嗎？
While ratings are subjective and will change, the latest Biora Therapeutics (BIOR) rating was a reiterated with a price target of $0.00 to $65.00. The current price Biora Therapeutics (BIOR) is trading at is $3.74, which is within the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的Biora Therapeutics（BIOR）評級得到了重申，目標股價爲0.00美元至65.00美元。Biora Therapeutics（BIOR）目前的交易價格爲3.74美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。